Credent Connect N Care IPO
Credent Connect N Care IPO: Overview
Credent Connect N Care Limited, a Delhi-based healthcare logistics and cold chain solutions company, opened its ₹93.90 crore SME IPO on August 13, 2026. The issue closes on August 17, 2026, with listing on the NSE SME platform expected on August 20, 2026.
The issue is structured as a fresh issue of ~₹93.90 crores; the offer document does not specify a distinct share count for an offer-for-sale component alongside it.
Credent Connect N Care IPO: Key Dates
|
Event |
Date |
|
Anchor Bidding Date |
August 12, 2026 |
|
IPO Open Date |
August 13, 2026 |
|
IPO Close Date |
August 17, 2026 |
|
Basis of Allotment |
August 18, 2026 |
|
Refunds Initiated |
August 19, 2026 |
|
Credit to Demat Account |
August 19, 2026 |
|
Listing Date (NSE SME) |
August 20, 2026 |
Credent Connect N Care IPO: Issue Details
|
Particular |
Detail |
|
Face Value |
₹10 per equity share |
|
Price Band |
₹179 to ₹189 per share |
|
Total Issue Size |
~₹93.90 crores |
|
Fresh Issue |
~₹93.90 crores |
|
Issue Type |
Book Building Issue |
|
Listing |
NSE SME |
IPO Reservation
|
Investor Category |
Shares Offered |
|
Anchor Investor |
14,04,000 shares |
|
QIB (ex-Anchor) |
9,48,000 shares |
|
NII |
7,08,000 shares (19.87%) |
|
Retail |
16,56,000 shares (46.46%) |
Credent Connect N Care IPO: Lot Size
|
Application |
Lots |
Shares |
Amount |
|
Retail (Min & Max) |
2 |
1,200 |
₹2,26,800 |
|
S-HNI (Minimum) |
3 |
1,800 |
₹3,40,200 |
|
S-HNI (Maximum) |
8 |
4,800 |
₹9,07,200 |
|
B-HNI (Minimum) |
9 |
5,400 |
₹10,20,600 |
As with most SME IPOs, retail investors face both a minimum and maximum cap of 2 lots, resulting in a fixed application amount of ₹2,26,800.
About Credent Connect N Care
Founded in 2015, Credent Connect N Care (operating as C3 Logistics) is a healthcare-focused logistics company offering cold chain solutions, warehousing, and supply chain services. Its core offering is B2B healthcare logistics — including transportation of diagnostic samples and reagent movement from carrying-and-forwarding agents to labs for in-vitro diagnostics (IVD) companies.
The company has built over 12 years of operating experience across 452 cities, employing more than 6,500 healthcare personnel, and offers services spanning logistics, phlebotomist services, and home sample collection.
Objects of the Issue
|
Purpose |
Amount |
|
Investment in subsidiary Credent Healthcare Pvt. Ltd. — working capital |
₹17.89 crores |
|
Investment in subsidiary Credent Healthcare Pvt. Ltd. — capex for machinery |
₹2.05 crores |
|
Working capital requirements (company level) |
₹26.30 crores |
|
Repayment/prepayment of borrowings |
₹4.12 crores |
|
General corporate purposes |
Balance amount |
Financial Performance
|
Period |
Revenue |
Expense |
PAT |
Assets |
|
FY2023 (Standalone) |
₹59.93 Cr |
₹56.19 Cr |
₹2.70 Cr |
₹19.49 Cr |
|
FY2024 (Standalone) |
₹76.02 Cr |
₹72.43 Cr |
₹2.66 Cr |
₹26.41 Cr |
|
FY2025 (Standalone) |
₹78.23 Cr |
₹75.23 Cr |
₹2.25 Cr |
₹29.50 Cr |
|
FY2026 (Consolidated) |
₹214.43 Cr |
₹189.83 Cr |
₹18.45 Cr |
₹81.57 Cr |
A few things worth noting here: standalone PAT was essentially flat — even declining slightly — from FY23 through FY25. The sharp jump in FY26 comes on a consolidated basis, reflecting the addition of subsidiary Credent Healthcare into the reported numbers, alongside a major revenue scale-up. When comparing standalone-only figures against this consolidated FY26 number, it's important not to read the jump as pure organic growth — a meaningful part of the increase reflects the change in reporting basis itself.
Key Valuation Metrics (FY2026)
|
KPI |
Value |
|
ROE |
40.00% |
|
ROCE |
61.81% |
|
EBITDA Margin |
13.29% |
|
PAT Margin |
8.61% |
|
Basic EPS |
₹13.95 |
|
RoNW |
42.13% |
|
Net Asset Value (NAV) |
₹33.12 |
How To Apply for the IPO ?
- Login or Open demat account with JM Financial Services / JM PRO app: Open the JM PRO app or JM Financial Services website and log in with your credentials.
- Locate the IPO Section: Navigate to the 'IPO' section on the platform.
- Select IPO: Find and select the IPO from the list of open IPOs.
- Enter the Lot Size: Specify the number of lots you want to bid for.
- Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
- Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
How To Check the Allotment Status of the IPO?
Steps to check IPO allotment status on JM Pro app:
- Log in to the JM Pro app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
JM Financial Services will notify you of your IPO allotment status via push notification and email
Frequently Asked Questions (FAQs)
Q1. What is the Credent Connect N Care IPO price band?
The price band is set at ₹179 to ₹189 per equity share.
Q2. When does the Credent Connect N Care IPO open and close?
The IPO opened on August 13, 2026, and closes on August 17, 2026.
Q3. What is the Credent Connect N Care IPO lot size?
The minimum (and maximum) retail lot is 1,200 shares, requiring a fixed application amount of ₹2,26,800 at the upper price band.
Q4. Is Credent Connect N Care a mainboard or SME IPO?
It is an SME IPO, listing on the NSE SME platform rather than the mainboard exchange.
Q5. What is the total issue size of the Credent Connect N Care IPO?
The total issue size is approximately ₹93.90 crores, structured entirely as a fresh issue.
Q6. What does Credent Connect N Care do?
Credent Connect N Care (C3 Logistics) provides healthcare-focused logistics, cold chain, and warehousing solutions, specialising in B2B transportation of diagnostic samples and reagents for IVD companies and labs.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. SME IPOs carry distinct risk characteristics, including lower trading liquidity, compared to mainboard IPOs. IPO details are based on publicly available offer documents and may be subject to change. Please read the offer documents carefully and consult a SEBI-registered financial advisor before making any investment decisions.
